EVP, Chief Technical Officer
Tue, Jun 20, 2023
Jun 20
exercised or converted securities in NTLA
5,000 shares @ $12.27
Increased holdings by +11.10%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+6.20%
1M+19.66%
3M+1.82%
6M—
1Y—